首页 › 基金 › Samsara BioCapital, LLC › AQST

Samsara BioCapital, LLC 对 AQST 的持仓历史

AQUESTIVE THERAPEUTICS INC · 医疗保健

Samsara BioCapital, LLC 在 Q3 2026 的 13F 申报中披露持有 AQST(AQUESTIVE THERAPEUTICS INC)2,434,367 股,市值约 US$11.3M,约占其申报组合的 1.07%,在其申报持仓中市值排名第 14 位。 Samsara BioCapital, LLC 最近 5 个申报季度中有 5 个季度披露了 AQST 持仓,最早可追溯至 Q3 2025。

最新持仓 (Q3 2026)2.43M 股
申报持仓市值$11.27M
组合权重1.07%
首次申报Q3 2025
最近变动减持
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Samsara BioCapital, LLC 对 AQST 的持仓演变

Samsara BioCapital, LLC 于 Q3 2025 首次披露 AQST 持仓:2,500,000 股(约 US$14.0M)。 该持仓在 Q4 2025 达到峰值 2,500,000 股,市值约 US$16.1M。 在 5 次申报中,Samsara BioCapital, LLC 0 次增持、1 次减持、3 次保持不变。 最近一期申报(Q3 2026)显示持股 2,434,367 股、市值约 US$11.3M,环比减持 -65,633 股。。

逐季持仓明细

季度股数金额变化
Q3 2025 2.50M $13.97M 新进
Q4 2025 2.50M $16.15M 持有
Q1 2026 2.50M $10.38M 持有
Q2 2026 2.50M $10.40M 持有
Q3 2026 2.43M $11.27M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 AQST 与 13F 数据

AQST(AQUESTIVE THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 AQST,申报仓位最大的包括:Bratton Capital Management, L.P. (US$45.4M), Rosalind Advisors, Inc. (US$9.3M), Propel Bio Management, LLC (US$8.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 AQST 的基金

查看 AQST 的全部基金持有人 →

常见问题

How long has Samsara BioCapital, LLC held AQST?

Samsara BioCapital, LLC has disclosed AQST holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Samsara BioCapital, LLC's current position in AQST?

As of Q3 2026, Samsara BioCapital, LLC holds 2.43M shares of AQST (AQUESTIVE THERAPEUTICS INC), valued at $11.27M, representing 1.07% of its reported portfolio and ranking #14.

Has Samsara BioCapital, LLC been buying or selling AQST?

In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC reduced its position in AQST. The position peaked in Q4 2025 at 2.50M shares.

Which other funds hold AQST?

Other major institutional holders of AQST include Bratton Capital Management, L.P., Rosalind Advisors, Inc., Propel Bio Management, LLC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.